Hydroxychloroquine's false hope: How an obscure drug became a coronavirus 'cure'
Links to Files
Permanent Link
Author/Creator ORCID
Date
Type of Work
Department
Program
Citation of Original Publication
Samuels, Elyse, Maurissa Tancharoen, Katherine Seley-Radtke, Joan Donovan and David Boulware. "Hydroxychloroquine's false hope: How an obscure drug became a coronavirus 'cure'" Washington Post. April 12, 2020. https://www.youtube.com/watch?v=QC-h7rnZW3k
Rights
This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
Abstract
Claims about hydroxychloroquine and chloroquine have taken hold of the global consciousness. Online conversations, media articles and politicians’ statements quickly - and incorrectly - labeled it as a ‘cure’ for covid-19, the disease caused by the novel coronavirus. Conversation around the drugs first spiked in mid-February after a Chinese news outlet tweeted about studies on the drugs. Word of the potential cure spread around the globe, reaching the U.S. in mid - March. A series of posts online, including a tweet by a blockchain investor, Elon Musk and President Trump, helped the idea gain traction. Trump has repeatedly championed hope in the drugs online and at press conferences. Yet scientists say there is only anecdotal evidence the drugs work to treat covid-19. Experts warn of lasting and dangerous consequences from promoting a drug with such a lack of scientific data it works. Already, a run on the drugs has caused a shortage for those who need it, like lupus and rheumatoid arthritis patients. The Fact Checker breaks down the data that shows when and how people began talking about hydroxychloroquine and chloroquine online - and highlights the fallout of overhyping drugs without concrete evidence